Get the Stockscreener App
78.15
1.90%
1.46
After Hours:
78.14
-0.01
-0.01%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $78.15, with a volume of 9.60M.
It is up +1.90% in the last 24 hours and up +3.66% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$76.69
Open:
$76.65
24h Volume:
9.60M
Relative Volume:
1.29
Market Cap:
$99.12B
Revenue:
$393.94B
Net Income/Loss:
$428.00M
P/E Ratio:
204.26
EPS:
0.3826
Net Cash Flow:
$6.29B
1W Performance:
-4.61%
1M Performance:
+3.66%
6M Performance:
+17.15%
1Y Performance:
+38.42%
1-Day Range:
$76.12
$78.22
1-Week Range:
$75.92
$85.15
52-Week Range:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
78.15 | 97.35B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
341.56 | 312.29B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
317.20 | 71.55B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
244.41 | 65.99B | 268.22B | 6.55B | 3.94B | 22.67 |
|
HUM
Humana Inc
|
278.19 | 34.35B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Is CVS Health Corporation stock a buy for dividend growth2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
CVS Health Corp. Hits Day Low of $75.92 Amid Price Pressure - Markets Mojo
Will CVS Health Corporation (Common Stock) (CVS0) stock profit from fiscal stimulusPortfolio Gains Summary & Free Community Supported Trade Ideas - newser.com
Is CVS Health Corporation stock positioned for digital transformationJuly 2025 Macro Moves & Real-Time Volume Triggers - newser.com
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earningsNew Guidance & Safe Entry Point Alerts - newser.com
CVS Health Corp. Hits New 52-Week High of $85.15 - Markets Mojo
How CVS Health Corporation (CVS) stock performs in easing cyclesWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Is it time to cut losses on CVS Health CorporationPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
Short interest data insights for CVS Health CorporationMarket Activity Report & Real-Time Chart Breakout Alerts - newser.com
[13F-HR] CVS HEALTH Corp SEC Filing - Stock Titan
CVS Health (NYSE: CVS) customers give $3M; company commits $2M to Feeding America - Stock Titan
Impact Partnership Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Carret Asset Management LLC - MarketBeat
CVS Health Corporation $CVS Stock Position Trimmed by Daymark Wealth Partners LLC - MarketBeat
Is CVS Health Corporation stock in correction or buying zoneMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
Will CVS Health Corporation (CVS) stock maintain strong growth2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Is CVS Health Corporation stock a top momentum playJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com
Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis - Law360
CVS Health to shut down 16 ‘underperforming' Oak Street Health clinics, including 1 in Chicago - MSN
CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results - Yahoo! Finance Canada
CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Ou - GuruFocus
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
CVS Health Grows Earnings And Outlook While Stock Stumbles - Finimize
Why CVS Health (CVS) Stock Is Falling Today - Barchart.com
CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong R - GuruFocus
CVS Health to shut down 16 Oak Street Health clinics, including 1 in Chicago - NBC 5 Chicago
CVS Health (CVS) Rating Maintained by RBC Capital with Raised Pr - GuruFocus
CVS Health tops Q3 forecasts but absorbs hefty charge for struggling clinic business - Idaho Business Review
CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | - GuruFocus
CVS Health (CVS) Analyst Rating Update: Target Price Raised by T - GuruFocus
CVS Health Stock Feels the Heat as $5.7B Write-Down Weighs on ‘Record’ Q3 - TipRanks
CVS Health Corporation (NYSE:CVS) Q3 2025 Earnings Call Transcript - Insider Monkey
Jennison Associates LLC Purchases 2,117,798 Shares of CVS Health Corporation $CVS - MarketBeat
CT health system, major insurer at odds over new contract. What it could mean for patients. - Hartford Courant
CVS Health forecasts double-digit earnings growth for 2026 By Reuters - Investing.com
CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook - Yahoo! Finance Canada
CVS Health Reports Record Revenue Despite Impairment - TipRanks
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit - Law360
UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target - Insider Monkey
CVS Health Earnings Call Highlights Robust Growth and Strategic Adjustments - TipRanks
CVS Health tops third-quarter forecasts but absorbs hefty charge for struggling clinic business - The Boston Globe
CVS Health posts record Q3 revenue despite $5.7B write-down - The Business Journals
CVS Health forecasts double-digit earnings growth for 2026 - Yahoo! Finance Canada
CVS Health (NYSE:CVS) Hits New 12-Month HighTime to Buy? - MarketBeat
CVS Posts Strong Q3 Earnings, but Shares Show Little Movement - AOL.com
CVS Health Earnings: Turnaround Efforts Proceeding and Could Continue Boosting Profits in 2026 - Morningstar
CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance - GuruFocus
CVS Health reports Q3 earnings beat, raises full-year guidance - Proactive financial news
CVS Health rethinks Oak Street Health strategy, raises guidance - Modern Healthcare
CVS Q3 tops Street but takes $5.3B charge on struggling health care delivery unit - Chain Store Age
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):